Showing results (21-30 of 24) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Japanese Journal of Clinical Oncology|February 3, 2026
Age-stratified clinical outcomes and adverse events in patients with metastatic castration-sensitive prostate cancer receiving triplet therapy with darolutamide, androgen deprivation therapy, and docetaxelTaizo Uchimoto, Kensuke Hirosuna, Heima Niigawa, et al.Japanese Journal of Clinical Oncology|October 19, 2025
Prognostic impact of lung metastasis in patients treated with androgen receptor signaling inhibitors for castration-sensitive prostate cancer: data from the ULTRA-Japan ConsortiumTaizo Uchimoto, Kensuke Hirosuna, Heima Niigawa, et al.Japanese Journal of Clinical Oncology|March 12, 2026
Real-world comparison of enzalutamide and apalutamide in metastatic hormone-sensitive prostate cancer: a multi-institutional propensity score-matched analysisKazuki Nishimura, Kensuke Hirosuna, Heima Niigawa, et al.International Journal of Clinical Oncology|October 29, 2024
Predicting time to castration resistance with androgen-receptor signaling inhibitors in hormone-sensitive prostate cancer: data from ULTRA-Japan ConsortiumTaizo Uchimoto, Kengo Iwatsuki, Kazumasa Komura, et al.Pageof 3